Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

US researchers have developed a tiny implantable device that automatically releases glucagon to prevent life-threatening low blood sugar in Type 1 diabetics, eliminating the need for emergency ...

MIT’s wireless skin implant delivers glucagon instantly when blood sugar drops, offering new safety for diabetics, even while ...

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

For individuals with Type 1 diabetes, the risk of hypoglycemia, dangerously low blood sugar, is a constant concern. When ...

A new implantable device developed by engineers at MIT can release glucagon without any external effort. The implant, which ...

Hormones can be helpful heroes, supporting the immune system and a healthy sleep-wake schedule. But they can also be culprits ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

A team of US researchers has developed a novel implantable device that can save people with Type 1 diabetes from developing ...

MIT engineers have made tremendous progress in revolutionising Type 1 diabetes management with their groundbreaking emergency ...

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan ...